Basics Verona Pharma Verona Pharma PLC develops drugs for respiratory diseases. Its products mainly include anti-inflammatory agents and bronchodilators. IPO Date: April 24, 2017 Sector: Healthcare Industry: Biotech Market Cap: $6.44B Activated in VL: True Average Daily Range Avg Daily Range: $0.40 | 2.86% Avg Daily Range (30 D): $1.49 | 2.18% Avg Daily Range (90 D): $1.78 | 2.87% Institutional Daily Volume Avg Daily Volume: .35M Avg Daily Volume (30 D): 1.32M Avg Daily Volume (90 D): 1.3M Trade Size Avg Trade Size (Sh.): 100 Avg Trade Size (Sh.) (30 D): 72 Avg Trade Size (Sh.) (90 D): 73 Institutional Trades Total Inst.Trades: 1,419 Avg Inst. Trade: $1.73M Avg Inst. Trade (30 D): $2.54M Avg Inst. Trade (90 D): $2.1M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $2.02M Avg Closing Trade (30 D): $3.51M Avg Closing Trade (90 D): $3.63M Avg Closing Volume: 50.66K         News May 30, 2025 @ 12:30 PM Regeneron, Sanofi Stock Falls After Uneven Smoker'... Source: Vandana Singh May 21, 2025 @ 10:00 AM Verona Pharma Announces June 2025 Investor Confere... Source: N/A May 6, 2025 @ 10:00 AM Verona Pharma to Present Seven Analyses of the Pha... Source: Verona Pharma Plc Apr 29, 2025 @ 10:00 AM Verona Pharma Reports First Quarter 2025 Financial... Source: Verona Pharma Apr 15, 2025 @ 10:00 AM Verona Pharma to Report First Quarter 2025 Financi... Source: N/A Financials   TTM Q1 2025 Q3 2024 Basic EPS $-.02 $-.07 Diluted EPS $-.02 $-.07 Revenue $ $ 76.26M $ 5.62M Gross Profit $ $ $ Net Income / Loss $ $ -16.32M $ -42.96M Operating Income / Loss $ $ -10.32M $ -40.67M Cost of Revenue $ $ $ Net Cash Flow $ $ 1.66M $ -68.56M PE Ratio